Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05983484
Other study ID # MYANT/PACE - 073-1819-7
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 16, 2023
Est. completion date February 1, 2024

Study information

Verified date February 2024
Source Myant Medical Corp.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to compare the electrocardiogram recording from Holter monitor with textile sensors (in the form of clothing) in patients diagnosed with arrhythmia. The study aims to answer the following questions: - Can the textile sensors provide continuous monitoring and detect arrhythmias? - Do patients prefer to wear textile sensors instead of the Holter? Participants that need Holter monitoring as part of their standard care will be invited to participate in the study. They will simultaneously wear both, the Holter monitor and the textile sensors for the time prescribed by their physician. Participants will also be asked to answer a questionnaire in the initial assessment and at the end of the study.


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date February 1, 2024
Est. primary completion date February 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Being addressed to the PACE cardiology clinic to perform an ECG due to a diagnosed or suspected cardiovascular disease. - Age above 18 - Understand and speak English enough to consent and answer the study questionnaire. - A medical need for Holter monitoring, and having a personal smartphone (iOS or Android), compatible with the Skiin app (application used to monitor the patient using the wearable device) Exclusion Criteria: - Pregnancy - Implanted defibrillator or pacemaker - Absence of garment fitting the participant's body - Open wound or dressing (e.g. band-aid) on a body part that needs to be in contact with the Skiin electrodes - Severe frailty such that donning or doffing the garment may cause a danger of fall. - Sensitive skin

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Skiin Underwear
All participants enrolled will wear simultaneously the PocketECG (Standard Holter) and the Skiin Underwear Chestband (wearable textile). Each participant will wear both systems for the duration prescribed by their physician (1 to 14 days).

Locations

Country Name City State
Canada Partners in Advanced Cardiac Evaluation (PACE) clinic Newmarket Ontario

Sponsors (2)

Lead Sponsor Collaborator
Myant Medical Corp. Partners in Advanced Cardiac Evaluation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in Usable ECG The duration of diagnostic ECG from PocketECG minus the duration of diagnostic ECG from Skiin underwear Throughout the entire data collection period, that is between 1 and 14 days
Primary Difference in Heart Rate The heart rate obtained from PocketECG minus the heart rate obtained from Skiin underwear Throughout the entire data collection period, that is between 1 and 14 days
Primary Difference in RR intervals The RR intervals obtained from PocketECG minus the RR intervals obtained from Skiin underwear Throughout the entire data collection period, that is between 1 and 14 days
Primary Arrhythmic events The number and proportion of arrhythmic events obtained by PocketECG and by Skiin underwear Throughout the entire data collection period, that is between 1 and 14 days
Secondary Patient's perception A questionnaire developed by Myant containing 10 questions related to the comfort, usability, ease of use and enjoyment will be applied to assess patients' perception of the Skiin underwear and of the PocketECG and to compare both systems, with answers on a 7 point Lickert Scale (from Strongly disagree to Strongly Agree, no numeric scoring). At the end of the study, 1 to 14 days after initiation.
See also
  Status Clinical Trial Phase
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT02241252 - Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients N/A
Completed NCT01428778 - Berlin Beat of Running Study N/A
Completed NCT01626261 - Examination of Implant´s Safety in an Electronic and Magnetic Field Environment
Withdrawn NCT01359683 - Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias N/A
Recruiting NCT04154982 - N-Acetylcysteine Protection Against Radiation Induced Cellular Damage Phase 2
Completed NCT04609683 - Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure N/A
Completed NCT04162249 - High Radiofrequency Power for Faster and Safer Pulmonary Veins Isolation - a Pilot Observational Study.
Withdrawn NCT05084391 - Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART) Phase 1/Phase 2
Completed NCT03260244 - EnSite Precision Observational Study
Recruiting NCT04474418 - Psychometric Characterization of Patients With Cardiac Arrhythmias
Recruiting NCT03996954 - Validation of a Smartphone-based Recorder for Detection of Cardiac Arrhythmias N/A
Recruiting NCT05508880 - SIGIL: Signal Interpretation and Analysis In Real Life Cardiac Arrhythmias
Terminated NCT04552665 - Prospective Procedural Data Collection for Continuous Improvement of the KODEX - EPD™ System Performance.
Recruiting NCT06073509 - Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
Completed NCT04463524 - Screening for Hearth Rhythm Disorders
Withdrawn NCT01394965 - Electrocardiographic Mapping and Imaging Phase 0
Completed NCT01672528 - Patient Reported Outcome Measures for Ablation of Cardiac Arrhythmias
Completed NCT02232204 - Sleep and Ventricular Arrhythmias Study Phase 2
Completed NCT05114382 - An Evaluation of the Safety and Performance of the CathVision Cube® System N/A